MEDIA RELEASE PR39113
Hill-Rom Announces Expansion of its Asia-Pacific Innovation Center in Singapore
SINGAPORE, Apr. 13 /PRNewswire-AsiaNet/ --
Grand opening event focuses on launch of two new R&D centers focused on
global respiratory care and patient support technology for emerging markets.
Singapore Senior Minister of State for Trade & Industry and Education Mr. S. Iswaran is guest of honor to
officially commemorate the opening.
Hill-Rom (NYSE: HRC) today announced that it has expanded its Asia-Pacific Innovation Center in
Singapore by opening two new Research and Development (R&D) centers of excellence at its Singapore
location. A celebration event was hosted today to commemorate the opening.
The new areas of focus include a Respiratory Care Development Center that will identify and develop
innovative global respiratory care products expanding beyond Hill-Rom's high frequency chest wall oscillation
therapy known as The Vest(R) Airway Clearance System. Also new is a Patient Support Development Center
that will focus on developing a variety of technology solutions for emerging markets.
"We are excited to expand our R&D efforts in Singapore related to innovation for respiratory care," said
John J. Greisch, president and CEO of Hill-Rom, who was present to host the event. "Importantly, this opening
reinforces our commitment to Asia as a key part of our growth plans."
Attending the opening event as the guest of honor, Mr. S. Iswaran, Senior Minister of State for Trade &
Industry and Education, Singapore, congratulated Hill-Rom on the expansion of its programs in Singapore.
"We are proud to be Hill-Rom's partner in its next chapter of growth. With our fundamentals in place and our
commitment to nurture med-tech innovators, we are well positioned to be a strategic partner for global med-
tech companies to grow and innovate in Asia," he said.
The Asia-Pacific Innovation Center officially opened in August 2008. Currently, 40 Hill-Rom employees work
at the location, comprising Hill-Rom's R&D teams, and sales and marketing staff in the region. The Innovation
Center in Singapore initially opened with 11,000 square feet of space and has now been expanded by an
additional 5,000 square feet to support the work in respiratory care. The respiratory care R&D teams will focus
on developing new technologies and products for the global mechanical airway clearance market while other
R&D teams continue to focus on products for the medical-surgical environment, new bed technologies and
connectivity solutions.
Hill-Rom's investment in the Asia-Pacific Innovation Center is part of a company-wide commitment to R&D.
Hill-Rom also has significant R&D activities at its global headquarters in Batesville, Ind. and in Cary, N.C., in
the United States, and in Lulea, Sweden and Montpelier and Pluvigner in France.
About Hill-Rom
Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for
the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive
therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, and
information technology solutions. Hill-Rom's comprehensive product and service offerings are used by health
care providers across the health care continuum and around the world in hospitals, extended care facilities
and home care settings to enhance the safety and quality of patient care.
Hill-Rom...enhancing outcomes for patients and their caregivers.
Disclosure Regarding Forward-Looking Statements
Certain statements in this press release contain forward-looking statements, within the meaning of the
Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs,
expectations, representations and projections. The Company has tried, wherever possible, to identify these
forward-looking statements using words such as:
"intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate,"
"strategy," "will," "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower,"
"reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them
or by comparable terminology. The absence of such terms, however, does not mean that the statement is not
forward-looking. It is important to note that forward-looking statements are not guarantees of future
performance, and the Company's actual results could differ materially from those set forth in any forward-
looking statements. Factors that could cause actual results to differ from forward-looking statements include
but are not limited to: the Company's dependence on its relationships with several large group purchasing
organizations, whether the Company's new products are successful in the marketplace, impacts of healthcare
reform, compliance with federal healthcare programs, collections of accounts receivable, compliance with FDA
regulations, antitrust litigation, potential exposure to product liability or other claims, failure of the Company's
announced or future strategic initiatives and restructuring and realignment activities to achieve expected
growth, efficiencies or cost reductions, adverse consequences resulting from the spin-off of the funeral
services business, failure of the Company to execute its acquisition and business alliance strategy through the
consummation and successful integration of acquisitions or entry into joint ventures or other business
alliances, increased costs or unavailability of raw materials, adverse changes in global economic conditions or
disruptions of credit markets, labor disruptions, the ability to retain executive officers and other key personnel,
liquidity of auction rate securities, and certain tax-related matters. For a more in depth discussion of these and
other factors that could cause actual results to differ from those contained in forward-looking statements, see
the discussions under the heading "Risk Factors" in the Company's previously filed Annual Report on Form
10-K for the period ended September 30, 2009, and the Quarterly Report on Form 10-Q for the quarter ended
December 31, 2009, previously filed. The Company assumes no obligation to update or revise any forward-
looking statements.
SOURCE: Hill-Rom
CONTACT: Hill-Rom Local Singapore
Contact: Howard Tam, Executive Director
Hill-Rom Services Private Limited
65-64997399
howard.tam@hill-rom.com
or Media: Lauren Green-Caldwell
Director, Corporate Communications & Public Relations
+1-812-934-8692
lauren.green-caldwell@hill-rom.com
Investor Relations: Blair A. (Andy) Rieth, Jr., Vice President,
Investor Relations, Corporate Communications &
Global Brand Development,
+1-812-931-2199
andy.rieth@hill-rom.com
NEWS 
